Report Type: Therapy Reports
Report Category: Respiratory
Report Subcategory: Acute Respiratory Distress Syndrome
Price: $ 2999.00
Date: January 2022

Acute Respiratory Distress Syndrome: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome is a condition in which fluid collects in the air sacs of the lungs, depriving organs of oxygen, occurs rapidly on its onset.

Top 10 Companies:
Bayer AG
Teva Pharmaceutical Industries Ltd
Daiichi Sankyo Co Ltd
Emergent BioSolutions Inc
Nippon Shinyaku Co Ltd
Hypera SA
BeiGene Ltd
Insmed Inc
Kamada Ltd
Athersys Inc